EARLY HEARING DETECTION AND INTERVENTION VIRTUAL CONFERENCE
MARCH 2-5, 2021
(Virtually the same conference, without elevators, airplane tickets, or hotel room keys)
10/25/2016 | 8:40 AM - 9:45 AM | Comparison of Oto-acoustic Emission Test and Automated Auditory Brainstem Response in Detecting Hearing loss among Newborns and Infants at a Tertiary Private Hospital | BGPOP Building 4A/B/C
Comparison of Oto-acoustic Emission Test and Automated Auditory Brainstem Response in Detecting Hearing loss among Newborns and Infants at a Tertiary Private Hospital
Hearing loss is a global burden, even in developed countries. Global estimates in developed countries revealed that 1 to 5 of 1000 babies are born deaf. Prevalence of hearing loss increases as parents’ literacy rate decreases.
Development of screening programs to identify persons with hearing loss is needed because the outcomes of this disability cascades throughout the person’s lifetime. Provision of a high quality of early intervention must be prioritized for the infants with hearing impairment to optimize their language and literacy development.
The goal of universal newborn hearing screening is to detect permanent hearing loss averaging 30dB or more in the frequency region important for speech recognition (500-4000 Hz). Several published studies have revealed weakness in the newborn hearing screening program. Some of the weaknesses are failure to detect late-onset deafness, and failure of some children who did not pass the initial screening to return for follow-up. Additionally, there are false-positive results in many newborn hearing screening programs. Consequently, centers began looking for ways to improve services by having a low failure rate yet also detect infants with congenital hearing loss.
The drawback in the Oto-acoustic Emission test is that it does not detect fluctuating hearing loss or those caused by auditory neuropathy. On the other hand, Automated Auditory Brainstem Response detects only moderate to profound hearing loss. These factors suggest a need to investigate the capability of Automated Auditory Brainstem Response as a screening tool for hearing loss among infants and compare that capability with the capability of the Oto-acoustic Emission protocol.
- To determine the demographic and clinicall profile of patients with hearing loss
- To determine the prevalence rate of hearing loss among infants born in a tertiary hospital
- To determine the sensitivity, specificity, positive predictive value and negative predictive value of AABR and OAE and ABR
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Cristopher Ed Gloria
(), University of Santo Tomas, cristopheredgloria@gmail.com;
Otolaryngology Head and Neck Surgery
University of Santo Tomas Hospital
Diplomate, Philippine Board of Otolaryngology Head and Neck Surgery
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Norberto Martinez
(), University of Santo Tomas, betterhearingphil@hotmail.com;
Professor, Department of Otolaryngology Head and Neck surgery, Faculty of Medicine and Surgery University of Santo Tomas
Past Chair, Department of Otolaryngology Head and Neck Surgery Faculty of Medicine and Surgery University of Santo Tomas
ASHA DISCLOSURE:
Financial -
Nonfinancial -